Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning provided an update regarding its ongoing CBD formula patents and medical device progress. Per the update, the prototyping of three CBD formula patents, which the company received a grant from the Government of Quebec to develop, has begun. The initial batch will be tested by the team and in vitro testing is expected to begin in summer 2019 to demonstrate the superior antioxidant activities and improved anti-proliferative effects on breast cancer cells. The third product is a superfood edible that is anticipated to be ready for Q4 of 2018. In addition, the company reported that it is currently working with Accélération, Design et Innovation Inc. regarding the final packaging of its MSN-2 medical device in preparation of its upcoming launch. “The official launch of this medical device is a little like giving birth. It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name. We will create a strong demand for this medical device by showing the world its powerful capacity to diminish the prevalence of chlamydia and other Sexually Transmitted Infections,” Earth Science Tech CEO and Chief Science Officer Dr. Michel Aubé stated in the news release.
To view the full press release, visit http://ibn.fm/oT7fN
About Earth Science Tech, Inc.
Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics prove it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
